Dr. Naraghi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2200 W 3rd St
Ste 300
Los Angeles, CA 90057Phone+1 213-480-8747Fax+1 213-480-9303
Education & Training
UPMC Medical EducationResidency, Urology, 1993 - 1997- UPMC Medical Education (Pittsburgh)Residency, Surgery, 1991 - 1993
Keck School of Medicine of the University of Southern CaliforniaClass of 1991
Certifications & Licensure
CA State Medical License 1997 - 2026
PA State Medical License 1991 - 1998- American Board of Urology Urology
Clinical Trials
- A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Start of enrollment: 2015 Sep 01
- A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease Start of enrollment: 2015 Sep 01
Publications & Presentations
PubMed
- 18 citationsEfficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.D Vu, T Shah, J Ansari, R Naraghi, D Min
Transplantation Proceedings. 2015-03-01 - 16 citationsInterferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.D Vu, Tariq Shah, Junaid Ansari, Prashant Sakharkar, Q Yasir
Transplant Infectious Disease. 2014-10-01 - 13 citationsAssociation of interferon gamma gene polymorphisms with BK virus infection among Hispanic renal allograft recipients.Don Vu, Prashant Sakharkar, Tariq Shah, Robert Naraghi, Qazi Yasir
Transplantation. 2014-03-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
